Key Highlights from the November 2024 Life Sciences Market Pulse by Outcome Capital
Article By Wara Samar / January 6, 2022
Outcome Capital, a premium advisory and investment banking firm specializing in life sciences and healthcare, has released its November 2024 issue of the Life Sciences Market Pulse. This comprehensive monthly report offers valuable insights into market trends, transaction activity, and emerging opportunities in the MedTech, biotech, diagnostics, and healthcare sectors. Below, we explore the key takeaways from this latest edition.
News
Averra Holdings and Banner Capital Announce Partnership with ZIEN Medical
PR Newswire / June 16, 2025 SALT LAKE CITY, June 16, 2025 /PRNewswire/ — Averra Holdings, LLC (“Averra”), a portfolio company of Banner Capital, is pleased to announce a partnership with ZIEN Medical Technologies (“ZIEN”). Read More
Read MoreResources
Outcome Capital Life Science Market Pulse, May 2025
Outcome Capital Life Science Market Pulse May 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
